New pill targets brain's 'drink drive' to curb alcohol cravings
NCT ID NCT06326684
First seen Jan 08, 2026 · Last updated May 09, 2026 · Updated 19 times
Summary
This study tests whether a drug that blocks orexin, a brain chemical linked to motivation, can reduce the desire to drink alcohol in people with Alcohol Use Disorder. Thirty adults who binge drink but are not seeking treatment will take the drug or a placebo and then choose between alcohol or money. The goal is to see if the drug lowers alcohol cravings and drinking choices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Psychopharmacology of Addiction Laboratory
RECRUITINGLexington, Kentucky, 40507, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.